Questions? Call 800-624-6242
add to cart
Rights & Permissions
. "Appendix C: The Critical Path to New Medical Products." The Threat of Pandemic Influenza: Are We Ready? Workshop Summary. Washington, DC: The National Academies Press, 2005.
Please select a format:
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
solution. In addition, FDA will make internal changes to intensify its ability to surface and address crucial issues and to support high-priority critical path research efforts.
Challenge and Opportunity on the Critical Path to New Medical Products (March 2004)
Full Report (PDF) Available: http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html
White Paper Executive Summary Available: http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html#execsummary
Critical Path News Release Available: http://www.fda.gov/bbs/topics/news/2004/NEW01035.html